Download Files:
395 CAD – 4,288 CADPrice range: 395 CAD through 4,288 CAD
Products Details
Product Description
– Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds to human complement protein C5 with high affinity, targeting complement factor 5 to block complement activation. It can be used for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis.
Web ID
– T76867
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– Lee JW, et, al. Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study. Blood. 2019 Feb 7;133(6):530-539.
CAS Number
– 1803171-55-2
Molecular Weight
Compound Purity
– > 95%
Pathway
– Immunology/Inflammation
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
Anti-SARS-CoV-2 Spike mAb (CR3022)
835 CAD – 1,389 CADPrice range: 835 CAD through 1,389 CAD
1000 in stock